Transpek Inds.

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE687A01016
  • NSEID: TRANSPEK
  • BSEID: 506687
INR
1,025.60
48.05 (4.92%)
BSENSE

Jun 12, 03:30 PM

BSE+NSE Vol: 11.53 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

11.53 k (182.96%) Volume

Shareholding (Mar 2026)

FII

0.02%

Held by 2 FIIs

DII

1.60%

Held by 1 DIIs

Promoter

57.47%

Why is Transpek Industry Ltd falling/rising?

12-Jun-2026

As of 11-Jun, Transpek Industry Ltd's stock price is at 977.55, showing a slight increase today but reflecting a troubling long-term decline of 43.36% over the past year. Despite today's minor gains, the stock's overall performance and decreasing investor participation indicate ongoing challenges.

As of 11-Jun, Transpek Industry Ltd's stock price is currently at 977.55, reflecting a change of 2.5 (0.26%) upward. This slight increase in price indicates a positive movement today, especially as the stock has outperformed its sector by 3.2%. Additionally, the stock reached an intraday high of Rs 1000, which is a 2.56% increase from its previous price.<BR><BR>However, despite this day's positive performance, the broader context shows significant declines over longer periods. The stock has fallen by 18.98% over the past month and 22.90% year-to-date. Over the last year, it has decreased by 43.36%, and over three years, it has plummeted by 55.25. These figures indicate a troubling trend for the stock, suggesting that while there may be short-term gains, the overall performance remains weak.<BR><BR>Investor participation appears to be declining, as evidenced by a 22.41% drop in delivery volume compared to the five-day average. This decline in investor engagement could contribute to the stock's longer-term downward trajectory. Furthermore, while the stock's price is currently higher than its five-day moving averages, it remains below the 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend in the longer term.<BR><BR>In summary, while Transpek Industry Ltd is experiencing a minor rise in price today, the overall performance metrics and declining investor participation suggest that the stock is still facing significant challenges.

View full answer

How big is Transpek Inds.?

11-Jun-2026

As of 10th June, Transpek Industry Ltd has a market capitalization of 559.00 Cr, with recent net sales of 621.20 Cr and a net profit of 45.65 Cr. Shareholder's funds are 745.32 Cr, and total assets amount to 1,000.54 Cr.

As of 10th June, Transpek Industry Ltd has a market capitalization of 559.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest 4 quarters, the company reported Net Sales of 621.20 Cr and a Net Profit of 45.65 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 745.32 Cr and Total Assets of 1,000.54 Cr.

View full answer

Who are in the management team of Transpek Inds.?

11-Jun-2026

The management team of Transpek Industries includes A C Shroff (Chairman), A G Shroff, Bimal V Mehta (Managing Director), D K Shroff, Ravi A Shroff, and several independent directors, totaling a diverse group that combines executive and independent perspectives.

The management team of Transpek Industries includes the following individuals:<BR><BR>1. A C Shroff - Chairman & Non-Executive Director<BR>2. A G Shroff - Non-Executive Director<BR>3. Bimal V Mehta - Executive Director / Managing Director / Non-Promoter<BR>4. D K Shroff - Non-Executive Director<BR>5. Ravi A Shroff - Non-Executive Director<BR>6. Bernd Dill - Independent Non-Executive Director<BR>7. Ninad D Gupte - Independent Non-Executive Director<BR>8. Nimishbhai U Patel - Independent Non-Executive Director<BR>9. Geeta Goradia - Independent Non-Executive Director<BR>10. Hemantkumar J Bhatt - Independent Non-Executive Director<BR>11. A M Tiwari - Independent Non-Executive Director<BR>12. Avtar Singh - Joint Managing Director<BR><BR>This diverse team brings a mix of executive and independent perspectives to the company's governance.

View full answer

Who are the peers of the Transpek Inds.?

11-Jun-2026

Transpek Inds. peers include Tuticorin Alkali, OCCL, Chemfab Alka, Vikram Thermo, Primo Chemicals, POCL Enterprises, Andhra Petrochem, Lords Chloro, Kanoria Chem, and Mangalam Organic. OCCL shows the best management and growth metrics, while Transpek Inds. has a 1-year return of -43.11%.

Peers: The peers of Transpek Inds. are Tuticorin Alkali, OCCL, Chemfab Alka., Vikram Thermo, Primo Chemicals, POCL Enterprises, Andhra Petrochem, Lords Chloro, Kanoria Chem., and Mangalam Organic.<BR><BR>Quality Snapshot: Excellent management risk is observed at OCCL, while Average management risk is found at Tuticorin Alkali, Chemfab Alka., Vikram Thermo, Primo Chemicals, Transpek Inds., POCL Enterprises, Andhra Petrochem, Lords Chloro, and Mangalam Organic, and Below Average management risk is noted at Kanoria Chem. and the rest. Growth is Excellent at OCCL and POCL Enterprises, Good at Tuticorin Alkali and Lords Chloro, while Below Average growth is seen at Chemfab Alka., Vikram Thermo, Primo Chemicals, Transpek Inds., Andhra Petrochem, and Mangalam Organic, with the rest showing Average growth. Capital Structure is Excellent at OCCL, Chemfab Alka., Vikram Thermo, and Andhra Petrochem, Good at Transpek Inds., Average at Primo Chemicals and Lords Chloro, and Below Average at POCL Enterprises and Kanoria Chem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is OCCL at 8.60%, while the lowest is Chemfab Alka. at -50.09%. Transpek Inds. has a 1-year return of -43.11%, which is higher than Chemfab Alka. but lower than OCCL. Additionally, the six-month return is negative for Chemfab Alka., Transpek Inds., POCL Enterprises, Andhra Petrochem, Lords Chloro, and Mangalam Organic.

View full answer

What does Transpek Inds. do?

10-Jun-2026

Transpek Industry Limited is a global supplier of chlorinated products, primarily serving the pharmaceuticals, agrochemicals, and dyes sectors. As of March 2026, it reported net sales of 148 Cr and a net profit of 7 Cr, with a market cap of INR 559 Cr.

Overview:<BR>Transpek Industry Limited is a leading global supplier of chlorinated products in the commodity chemicals industry, focusing on sectors such as pharmaceuticals, agrochemicals, and dyes.<BR><BR>History:<BR>Transpek Industry Limited was incorporated in an unspecified year and has maintained its status as a micro-cap company. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 148 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 7 Cr (Quarterly Results - Mar 2026)<BR>- Market-cap: INR 559 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 12.00<BR>- Industry P/E: 42<BR>- Dividend Yield: 2.05%<BR>- Debt Equity: -0.07<BR>- Return on Equity: 5.95%<BR>- Price to Book: 0.71<BR><BR>Contact Details:<BR>Address: 4th Floor, Gotri Sevasi Road Vadodara Gujarat : 390021<BR>Tel: 91-265-2335444/2335446/2335447/141<BR>Email: secretarial@transpek.com<BR>Website: http://www.transpek.com

View full answer

Should I buy, sell or hold Transpek Industry Ltd?

03-Jun-2026

Are Transpek Industry Ltd latest results good or bad?

27-May-2026

Transpek Industry Ltd's latest Q4 FY26 results are concerning, showing a 65.82% year-on-year decline in net profit and a significant drop in operating margins to 11.96%. Overall, the company faces challenges in profitability and operational efficiency, indicating a negative outlook for investors.

Transpek Industry Ltd's latest results for Q4 FY26 indicate a troubling performance. The company reported a net profit of ₹6.58 crores, which represents a significant decline of 65.82% year-on-year and 39.35% quarter-on-quarter. Additionally, net sales fell to ₹148.22 crores, marking a 10.31% decrease year-on-year and a 6.47% decline from the previous quarter. <BR><BR>The operating margin has also contracted sharply, dropping to 11.96%, down from 19.50% in the same quarter last year. This decline in margins reflects ongoing operational challenges and pressures on profitability. The company's reliance on other income has raised concerns about the sustainability of its earnings, as nearly half of its profit before tax came from non-operating sources.<BR><BR>Overall, these results suggest that Transpek Industry is facing significant difficulties in maintaining its operational efficiency and profitability, leading to a negative outlook for the company. Investors should be cautious given the consistent decline in key financial metrics and the lack of visible catalysts for recovery.

View full answer

Is Transpek Inds. technically bullish or bearish?

20-Nov-2025

As of November 19, 2025, Transpek Inds. has a bearish technical trend with moderate strength, indicated by bearish daily moving averages and Bollinger Bands, while the MACD and KST show mixed signals, contributing to its underperformance compared to the Sensex.

As of 19 November 2025, the technical trend for Transpek Inds. has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this stance include the bearish signals from the daily moving averages and the Bollinger Bands on both weekly and monthly time frames. The MACD shows a mildly bullish signal on the weekly but is bearish on the monthly, indicating a lack of consistent momentum. Additionally, the KST is mildly bullish on the weekly but bearish on the monthly, further supporting the bearish outlook. Overall, the stock has underperformed significantly compared to the Sensex across multiple time frames, reinforcing the bearish sentiment.

View full answer

Is Transpek Inds. overvalued or undervalued?

18-Nov-2025

As of November 17, 2025, Transpek Industries is fairly valued with a PE ratio of 13.02, making it an attractive investment compared to its peers, despite a year-to-date return of -13.69%.

As of 17 November 2025, the valuation grade for Transpek Industries has moved from expensive to fair. The company is currently fairly valued, with a PE ratio of 13.02, a Price to Book Value of 0.99, and an EV to EBITDA of 6.53. These ratios indicate a reasonable valuation compared to its peers in the commodity chemicals sector.<BR><BR>In comparison to its peers, Transpek's valuation appears attractive, especially when contrasted with Solar Industries, which has a PE ratio of 95.31, and Gujarat Fluoroch, with a PE of 57.85, both classified as very expensive. Additionally, Aarti Industries, another peer, has a fair valuation with a PE of 53.15. Despite recent stock performance lagging behind the Sensex, with a year-to-date return of -13.69% compared to the Sensex's 8.72%, the current valuation metrics suggest that Transpek Industries offers a compelling investment opportunity within its sector.

View full answer

How has been the historical performance of Transpek Inds.?

17-Nov-2025

Transpek Inds. experienced fluctuating financial performance, with net sales increasing to 649.85 Cr in March 2025 but declining from 826.90 Cr in March 2023. Despite revenue challenges, the company showed resilience with improved operating profit, profit before tax, and cash flow from operating activities.

Answer:<BR>The historical performance of Transpek Inds. shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Transpek Inds. reported net sales of 649.85 Cr in March 2025, an increase from 579.63 Cr in March 2024, but a decline from 826.90 Cr in March 2023. The total operating income followed a similar pattern, reaching 649.85 Cr in March 2025 compared to 579.63 Cr in the previous year. The raw material cost rose to 330.33 Cr in March 2025 from 293.86 Cr in March 2024, contributing to a total expenditure of 555.17 Cr, up from 497.32 Cr in March 2024. Operating profit (PBDIT) increased to 123.39 Cr in March 2025 from 107.47 Cr in March 2024, while profit before tax also rose to 61.66 Cr from 55.51 Cr. However, profit after tax saw a more modest increase to 48.74 Cr from 38.56 Cr. The earnings per share (EPS) improved to 87.19 in March 2025 from 68.98 in March 2024. On the balance sheet, total assets grew to 1,000.54 Cr in March 2025 from 965.67 Cr in March 2024, and total liabilities also increased to 1,000.54 Cr from 965.67 Cr. Cash flow from operating activities rose to 135.00 Cr in March 2025 from 97.00 Cr in March 2024, indicating improved cash generation capabilities. Overall, while Transpek Inds. faced some challenges in revenue, it demonstrated resilience in profitability and asset growth.

View full answer

Who are the top shareholders of the Transpek Inds.?

06-Jun-2025

The top shareholders of Transpek Industries include Anshul Specialty Molecules Private Limited with 24.64%, individual investors holding 31.39%, and Mukul Mahavir Agrawal as the largest public shareholder at 2.12%. There are no pledged promoter holdings or mutual funds invested in the company.

The top shareholders of Transpek Industries include the promoters, who hold the majority of the shares. The promoter with the highest holding is Anshul Specialty Molecules Private Limited, which owns 24.64% of the company. Additionally, individual investors collectively hold 31.39% of the shares. In terms of public shareholders, Mukul Mahavir Agrawal is the highest with a holding of 2.12%. There are also three foreign institutional investors (FIIs) that hold a small percentage of 0.03%. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

View full answer

When is the next results date for Transpek Inds.?

06-Jun-2025

No Upcoming Board Meetings

Has Transpek Inds. declared dividend?

06-Jun-2025

Transpek Industry Ltd has declared a 140% dividend, amounting to ₹14 per share, with an ex-date of September 13, 2024. While the company shows mixed total returns over various periods, it has experienced negative returns in the short term and positive trends in the longer term.

Transpek Industry Ltd has declared a 140% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 140%<BR>- Amount per share: 14<BR>- Ex-date: 13 Sep 24<BR><BR>Dividend Yield: 0.87%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -1.75%, the dividend return was 0%, resulting in a total return of -1.75%.<BR><BR>Over the past year, the price return was -5.14%, the dividend return was 0.78%, leading to a total return of -4.36%.<BR><BR>In the last 2 years, the price return was -18.2%, the dividend return was 1.94%, which resulted in a total return of -16.26%.<BR><BR>For the 3-year period, the price return was 0.89%, the dividend return was 4.46%, culminating in a total return of 5.35%.<BR><BR>In the 4-year span, the price return was 8.12%, the dividend return was 4.36%, producing a total return of 12.48%.<BR><BR>Over the last 5 years, the price return was -7.51%, the dividend return was 4.76%, resulting in a total return of -2.75%.<BR><BR>Overall, Transpek Industry Ltd has declared a substantial dividend, but the total returns over various periods show a mixed performance, with negative returns in the shorter terms and a positive trend in the longer terms.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of 12.85% and Operating profit at 19.16% over the last 5 years

 
2

With a fall in Net Sales of -6.47%, the company declared Very Negative results in Mar 26

3

Despite the size of the company, domestic mutual funds hold only 0% of the company

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 552 Cr (Micro Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

41

stock-summary
Dividend Yield

2.02%

stock-summary
Debt Equity

-0.07

stock-summary
Return on Equity

5.95%

stock-summary
Price to Book

0.72

Revenue and Profits:
Net Sales:
148 Cr
(Quarterly Results - Mar 2026)
Net Profit:
7 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (2.02%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.31%
0%
12.31%
6 Months
-17.41%
0%
-17.41%
1 Year
-40.58%
1.17%
-39.41%
2 Years
-42.38%
1.89%
-40.49%
3 Years
-51.87%
2.80%
-49.07%
4 Years
-35.0%
5.16%
-29.84%
5 Years
-34.44%
5.13%
-29.31%

Latest dividend: 20 per share ex-dividend date: Aug-26-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Transpek Industry Ltd Falls 12.64%: 5 Key Factors Behind the Sharp Weekly Decline

Announcements stock-summary

Intimation Of Receipt Of Approval For Reclassification Application Of Promoter Under Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

02-Jun-2026 | Source : BSE

Company has received approval from BSE Limited for the reclassification of Promoter shareholder Malti Dilipsinh Bhatia as Public shareholder.

Intimation Of Receipt Of Approval For Reclassification Application Of Promoter Under SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

02-Jun-2026 | Source : BSE

Company has received an approval from BSE Limited for reclassification of Promoter shareholder Malti Dilipsinh Bhatia as Public shareholder

Announcement under Regulation 30 (LODR)-Newspaper Publication

28-May-2026 | Source : BSE

Intimation of e-copies of results published in newspapers.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Transpek Industry Ltd has declared 200% dividend, ex-date: 26 Aug 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
12.85%
EBIT Growth (5y)
19.16%
EBIT to Interest (avg)
4.94
Debt to EBITDA (avg)
0.85
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.90
Tax Ratio
25.41%
Dividend Payout Ratio
22.92%
Pledged Shares
0
Institutional Holding
1.62%
ROCE (avg)
9.76%
ROE (avg)
9.19%

Valuation key factors

Factor
Value
P/E Ratio
13
Industry P/E
41
Price to Book Value
0.76
EV to EBIT
11.72
EV to EBITDA
5.62
EV to Capital Employed
0.74
EV to Sales
0.84
PEG Ratio
NA
Dividend Yield
1.93%
ROCE (Latest)
6.29%
ROE (Latest)
5.95%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Bearish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (0.02%)

Promoter with highest holding

Anshul Specialty Molecules Private Limited (24.64%)

Highest Public shareholder

Mukul Mahavir Agrawal (2.12%)

Individual Investors Holdings

31.17%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -6.47% vs -1.12% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -39.35% vs -14.16% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "148.22",
          "val2": "158.48",
          "chgp": "-6.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.73",
          "val2": "24.93",
          "chgp": "-28.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.52",
          "val2": "1.67",
          "chgp": "-8.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.58",
          "val2": "10.85",
          "chgp": "-39.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.96%",
          "val2": "15.73%",
          "chgp": "-3.77%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -0.02% vs 11.11% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 49.79% vs 0.00% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "314.51",
          "val2": "314.56",
          "chgp": "-0.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "50.74",
          "val2": "38.53",
          "chgp": "31.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.87",
          "val2": "5.83",
          "chgp": "-16.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "28.22",
          "val2": "18.84",
          "chgp": "49.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.13%",
          "val2": "12.25%",
          "chgp": "3.88%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -2.40% vs 12.33% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 32.49% vs -10.42% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "472.99",
          "val2": "484.60",
          "chgp": "-2.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "75.67",
          "val2": "62.47",
          "chgp": "21.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.54",
          "val2": "8.95",
          "chgp": "-26.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "39.07",
          "val2": "29.49",
          "chgp": "32.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.00%",
          "val2": "12.89%",
          "chgp": "3.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -4.41% vs 12.11% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -6.34% vs 26.40% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "621.20",
          "val2": "649.85",
          "chgp": "-4.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "93.39",
          "val2": "94.68",
          "chgp": "-1.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "8.06",
          "val2": "11.74",
          "chgp": "-31.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "45.65",
          "val2": "48.74",
          "chgp": "-6.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.03%",
          "val2": "14.57%",
          "chgp": "0.46%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
148.22
158.48
-6.47%
Operating Profit (PBDIT) excl Other Income
17.73
24.93
-28.88%
Interest
1.52
1.67
-8.98%
Exceptional Items
0.00
0.00
Consolidate Net Profit
6.58
10.85
-39.35%
Operating Profit Margin (Excl OI)
11.96%
15.73%
-3.77%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is -6.47% vs -1.12% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -39.35% vs -14.16% in Dec 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
314.51
314.56
-0.02%
Operating Profit (PBDIT) excl Other Income
50.74
38.53
31.69%
Interest
4.87
5.83
-16.47%
Exceptional Items
0.00
0.00
Consolidate Net Profit
28.22
18.84
49.79%
Operating Profit Margin (Excl OI)
16.13%
12.25%
3.88%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -0.02% vs 11.11% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 49.79% vs 0.00% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
472.99
484.60
-2.40%
Operating Profit (PBDIT) excl Other Income
75.67
62.47
21.13%
Interest
6.54
8.95
-26.93%
Exceptional Items
0.00
0.00
Consolidate Net Profit
39.07
29.49
32.49%
Operating Profit Margin (Excl OI)
16.00%
12.89%
3.11%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -2.40% vs 12.33% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 32.49% vs -10.42% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
621.20
649.85
-4.41%
Operating Profit (PBDIT) excl Other Income
93.39
94.68
-1.36%
Interest
8.06
11.74
-31.35%
Exceptional Items
0.00
0.00
Consolidate Net Profit
45.65
48.74
-6.34%
Operating Profit Margin (Excl OI)
15.03%
14.57%
0.46%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -4.41% vs 12.11% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -6.34% vs 26.40% in Mar 2025

stock-summaryCompany CV
About Transpek Industry Ltd stock-summary
stock-summary
Transpek Industry Ltd
Micro Cap
Commodity Chemicals
Transpek Industry Limited is a leading global supplier for chlorinated products to various industry sectors ranging from Pharmaceuticals, Agrochemicals and dyes to pigments. The Company has an excellent experience in manufacturing of products using chlorinated chemistry presenting unending opportunities for supply of intermediates and speciality chemicals suitable for multiple applications.
Company Coordinates stock-summary
Company Details
4th Floor, Gotri Sevasi Road Vadodara Gujarat : 390021
stock-summary
Tel: 91-265-2335444/2335446/2335447/141
stock-summary
secretarial@transpek.com
Registrar Details
Link Intime India Pvt Ltd., B-102 & B103, Shangrila Complex, First Floor, Opp: HDFC Bank, Near Radhakrishna Char Rasta, Akota, Vadodara